The 7th edition of the ESMO Symposium on Signalling Pathways in Cancer, in partnership with the European Association for Cancer Research (EACR), will focus on Gene fusions: from gene architecture evolution, cell addiction and exploring new therapeutic opportunities.
The aim of the symposium is to foster strategic collaboration among basic scientists, translational and clinical researchers to discuss diagnostic challenges and the future of new therapies. Focusing on the topic of gene fusions and oncogenic fusion in different cancer types will result in promising new insights from Symposium participants.
EACR members are eligible for reduced registration rates
Application deadline: 25 January 2019
We will award up to 5 bursaries to assist members of the European Association for Cancer Research to attend the Symposium. The bursaries provide a registration and funds to support travel and accommodation.
This is considered an out of date browser. This website has been developed with modern browsers in mind to allow it to display at its best in a wide variety of viewing situations - including mobile viewing. But we haven't supported older browsers like IE8. Please upgrade to the latest version of Internet Explorer - or try Mozilla Firefox or Google Chrome. Both are excellent browsers.